Sonova Holding AG banner

Intrinsic Value

The intrinsic value of Sonova Holding AG (PHBN) under the Base Case is 300.11 EUR per share. Compared with the current market price of 308.7 EUR, the stock appears Overvalued by 3% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

PHBN Intrinsic Value
€300.11
Overvaluation 3%
Intrinsic Value
Price €308.7
Alert me when PHBN is below its intrinsic value
Today €240.09 · 22.2% below the current price

PHBN is more expensive than usual. It was this expensive or more expensive on less than 1% of days in the past 5 years.

Alternatives to PHBN

Fundamental Analysis

What Sonova Does

Health Care

Sonova Holding AG makes hearing care products and services. It designs and sells hearing aids, cochlear implants, wireless communication systems, and related accessories under brands used by hearing-care professionals and end customers. The company also offers audiology services and support tools that help people test, fit, and maintain their hearing devices.

Headquarters
Switzerland CH
Employees
18 580
IPO date
Apr 23, 2009
Read the full company overview
View Company Overview

Sonova Holding has no economic moat

No Moat Narrow Wide

Several established manufacturers offer competing hearing aids, and Sonova sells through independent providers as well as its own stores. Buyers and providers can therefore choose alternatives; Sonova’s brands and size alone do not keep rivals from winning sales.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue PHBN Research

Decided on Sonova Holding? Get an email when PHBN reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one PHBN stock?

The intrinsic value for Sonova Holding AG (PHBN) under the Base Case is 300.11 EUR.

Is PHBN stock undervalued or overvalued?

Compared with the current market price of 308.7 EUR, the stock appears Overvalued by 3% .

How reliable are our estimates? See how past valuations played out
Back to Top